Ladd Dental Group

 The fact that 23 large U.S. DSOs are reportedly in receivership has significant implications for dental practice valuations , private equity behavior, and the broader dental consolidation landscape. Here's a breakdown of how this development is likely to affect dental practice valuations moving forward: 🧮 1. Downward Pressure on Multiples Practice valuations will likely decline , especially for DSOs heavily dependent on aggressive growth strategies and high debt. Investors will become more cautious, lowering EBITDA multiples due to increased perceived risk. Before: 6–10x EBITDA was common for group practices. Now: 4–7x may become the new norm, especially for general dentistry offices without strong margins or growth. 🧯 2. Decreased PE Appetite for Over-Leveraged DSOs These receiverships serve as a wake-up call to private equity that scaling without strong operations, cash flow, and clinician retention is unsustainable. Future investors will emphasize fi...

 Industry updates (like those from the Dykema annual conference) note that 23 DSOs have entered receivership in the past year, but the specific identities of those organizations are not disclosed in available legal, financial, or DSO trade publications. This lack of transparency is common. Receivership filings are typically single-case documents and may not be widely reported unless the DSO is a major national player or there are noteworthy creditor or legal implications. Most smaller to mid-sized DSOs in receivership quietly go through court proceedings without broader media coverage. 🕵️ Why the Specifics Aren’t Public Court filings are case-specific and rarely summarized via trade media. Non-disclosure agreements (NDAs) and confidentiality may restrict reporting in industry newsletters. Small DSOs often receive little mainstream attention when entering receivership. ✅ Recommended Next Steps if You're Monitoring: PACER (Public Access to Court Electronic Re...